YOLFTbeta
Bausch Health Companies Inc

Bausch Health Companies Inc

BHC · NYSE · Healthcare / Drug Manufacturers - Specialty & Generic

8.35USD+0.10 (+1.21%)

Price History

Full chart

Market Stats

Previous Close8.25
Open8.25
Day Range8.18 – 8.40
52-Week Range4.33 – 9.04
Volume2.34M
Market Cap3.33B
P/E (TTM)0.00
Forward P/E1.55
EPS-2.95
Dividend Yield0.00%
Beta0.37
50-Day Avg6.21
200-Day Avg5.70

About

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, Czech Republic, Slovakia, Ukraine, Bulgaria, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Thomas J. Appio
  • Employees20.30K
  • Headquarters2150 St. Elzéar Blvd. West, Laval, QC, Canada, H7L 4A8, USA
  • Websitehttps://www.bauschhealth.com

Leadership

  • Mr. Thomas J. AppioCEO & Director · b. 1962
  • Mr. Jean-Jacques CharhonExecutive VP & CFO · b. 1965
  • Ms. Seana CarsonExecutive VP & General Counsel · b. 1973
  • Ms. Aimee J. LenarPresident of US Pharma · b. 1976
  • Mr. Mirza DautbegovicExecutive VP & COO
  • Mr. Steven H. LeeSenior VP, Controller & Chief Accounting Officer · b. 1971
  • Mr. Garen SarafianVP & Head of Investor Relations
  • Ms. Kathleen FitzpatrickExecutive VP and Chief HR & Communications Officer
  • Mr. Cees HeimanSenior Vice President of Europe & Canada
  • Ms. Jiny Kim M.B.A.Senior Vice President of Solta Medical · b. 1977

Financials

Income Statement

Currency: USD1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue11.10M17.30M20.60M66.40M82.40M112.80M176.50M309.17M583.26M788.02M823.72M886.54M935.54M1.07B842.82M757.18M820.43M1.15B2.46B3.48B5.77B8.20B10.44B9.67B8.72B8.38B8.60B8.03B8.43B8.12B8.76B9.63B10.27B
Growth (%)-+55.86%+19.08%+222.33%+24.10%+36.89%+56.47%+75.17%+88.65%+35.11%+4.53%+7.63%+5.53%+14.42%-21.27%-10.16%+8.35%+39.70%+114.94%+41.28%+65.66%+42.22%+27.34%-7.35%-9.82%-3.94%+2.64%-6.67%+5.07%-3.68%+7.79%+9.91%+6.66%
Cost of Revenue2.10M4.30M4.20M23.20M27.70M23.60M28.20M68.03M126.00M164.71M139.46M229.53M206.82M223.27M223.68M197.17M325.09M405.75M726.83M890.90M1.53B2.20B2.45B2.57B2.55B2.35B2.35B2.25B2.39B2.36B2.56B2.78B3.01B
Gross Profit9.00M13.00M16.40M43.20M54.70M89.20M148.30M241.14M457.27M623.32M684.27M657.01M728.72M847.21M619.14M560.01M495.34M740.38M1.74B2.59B4.24B6.00B8.00B7.10B6.18B6.03B6.25B5.78B6.04B5.76B6.20B6.84B7.25B
Gross Margin81.08%75.14%79.61%65.06%66.38%79.08%84.02%78.00%78.40%79.10%83.07%74.11%77.89%79.14%73.46%73.96%60.38%64.60%70.50%74.40%73.49%73.13%76.58%73.40%70.79%71.95%72.68%71.98%71.61%70.90%70.78%71.10%70.65%
Operating Expense9.20M10.22M13.80M19.70M17.20M40.10M72.80M110.75M205.63M489.04M679.47M435.74M415.44M392.85M431.12M363.89M314.18M850.46M1.21B2.51B4.65B4.00B6.47B7.67B6.07B8.41B6.45B5.10B5.59B5.31B5.24B5.30B5.07B
Operating Income-200.00K2.78M2.60M23.50M37.50M49.10M75.50M130.39M251.64M134.28M4.79M221.28M313.28M454.36M188.01M196.12M181.15M-110.08M525.32M79.69M-409.50M2.00B1.53B-566.00M102.00M-2.38B-203.00M676.00M450.00M454.00M963.00M1.55B2.19B
Operating Margin-1.80%16.06%12.62%35.39%45.51%43.53%42.78%42.17%43.14%17.04%0.58%24.96%33.49%42.44%22.31%25.90%22.08%-9.60%21.32%2.29%-7.10%24.40%14.62%-5.85%1.17%-28.45%-2.36%8.42%5.34%5.59%11.00%16.06%21.28%
EBITDA500.00K3.56M200.00K25.50M40.70M54.10M85.60M151.92M319.50M391.99M272.27M323.60M440.79M349.73M289.45M230.83M349.10M102.55M918.71M1.79B3.45B3.91B5.11B4.07B3.41B3.32B3.42B3.14B3.26B2.88B2.88B3.13B3.18B
EBITDA Margin4.50%20.59%0.97%38.40%49.39%47.96%48.50%49.14%54.78%49.74%33.05%36.50%47.12%32.67%34.34%30.49%42.55%8.95%37.29%51.41%59.90%47.71%48.89%42.08%39.12%39.61%39.73%39.09%38.65%35.43%32.95%32.56%30.97%
Net Income3.90M9.50M5.90M22.70M35.20M45.40M62.50M-147.98M87.45M87.80M-40.34M160.99M246.44M210.00M195.54M199.90M176.46M-208.19M159.56M-116.03M-866.14M881.00M-268.66M-2.41B2.40B-4.15B-1.78B-559.00M-948.00M-225.00M-592.00M-46.00M157.00M
Net Income Margin35.14%54.91%28.64%34.19%42.72%40.25%35.41%-47.86%14.99%11.14%-4.90%18.16%26.34%19.62%23.20%26.40%21.51%-18.16%6.48%-3.33%-15.02%10.74%-2.57%-24.90%27.56%-49.50%-20.73%-6.96%-11.24%-2.77%-6.76%-0.48%1.53%
R&D---7.50M-17.50M33.10M52.66M51.02M52.15M86.57M72.50M88.88M95.47M118.12M92.84M14.15M157.56M174.89M79.10M156.80M266.00M440.00M469.00M369.00M442.00M516.00M485.00M473.00M530.00M604.00M634.00M629.00M
R&D as % of Total Revenue---11.30%-15.51%18.75%17.03%8.75%6.62%10.51%8.18%9.50%8.92%14.01%12.26%1.72%13.75%7.10%2.27%2.72%3.24%4.21%4.85%4.23%5.27%6.00%6.04%5.61%6.52%6.90%6.59%6.13%
Interest Expense0000000000000001.02M25.42M84.31M330.44M481.60M844.32M971.00M1.56B1.84B1.84B1.69B1.61B1.53B1.43B1.46B1.33B1.39B1.60B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.13%3.10%7.36%13.41%13.84%14.64%11.84%14.97%18.98%21.09%20.11%18.74%19.11%16.91%18.02%15.17%14.42%15.62%

Balance Sheet

Currency: USD1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets23.30M25.60M60.90M58.60M93.70M199.90M635.10M1.11B1.33B1.83B1.92B2.01B2.19B2.18B1.78B1.62B2.07B10.80B13.14B17.95B27.97B26.35B48.96B43.53B37.50B27.45B33.86B31.20B29.20B25.69B27.35B26.52B26.32B
Total Liabilities25.90M17.96M46.30M21.70M18.20M148.70M204.88M869.81M205.41M988.12M1.03B657.15M808.44M890.18M484.30M421.97M704.92M5.88B9.18B14.23B22.74B20.90B42.94B40.27B31.55B29.68B32.73B30.59B29.24B25.43B27.43B26.84B25.94B
Total Equity-4.80M7.70M14.60M36.90M75.50M51.20M267.34M237.46M1.13B845.69M1.27B1.05B1.22B1.30B1.30B1.20B1.35B4.91B3.93B3.72B5.12B5.28B5.91B3.15B5.85B2.73B1.06B605.00M-34.00M-692.00M-1.02B-1.28B-552.99M
Cash2.70M2.80M24.30M4.50M8.30M78.30M178.10M125.14M434.89M56.08M133.26M34.32M445.29M834.50M433.64M317.55M114.46M394.27M164.11M916.09M600.34M322.60M597.30M542.00M720.00M721.00M3.24B605.00M582.00M564.00M947.00M1.18B1.32B
Total Debt21.60M6.20M10.20M7.00M4.90M126.90M137.50M738.73M46.16M747.35M812.53M478.94M436.86M410.52M-63.70M392.29M3.69B6.65B11.03B17.38B15.24B31.10B29.85B25.44B24.30B25.89B23.98B22.70B20.77B22.39B21.83B21.21B
Net Debt18.90M3.35M-14.10M2.50M-3.40M48.60M-40.58M613.59M-388.73M691.27M679.26M444.61M-8.42M-424.01M-433.64M-253.85M277.82M3.30B6.49B10.11B16.78B14.91B30.51B29.30B24.72B23.58B22.65B23.32B22.07B20.20B21.44B20.65B19.88B

Cash Flow

Currency: USD1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.10M2.60M31.10M-5.60M4.30M53.60M81.00M102.49M284.12M334.10M281.98M277.09M498.11M521.93M340.85M204.32M360.90M263.19M676.47M656.58M1.04B2.29B2.20B2.09B2.29B1.50B1.50B1.11B1.43B-728.00M1.03B1.60B1.40B
Investing Cash Flow-1.10M-3.00M--10.40M-3.20M-33.00M-129.40M-582.30M-57.75M-792.47M-278.45M-42.26M31.78M-40.45M-15.04M-107.83M-742.77M228.94M-2.84B-2.97B-5.38B-99.70M-15.58B-125.00M2.89B-196.00M-419.00M-261.00M409.00M-303.00M-2.15B-454.00M-595.00M
Financing Cash Flow3.90M400.00K300.00K-3.00M2.60M49.50M147.90M427.05M83.60M79.53M72.52M-334.53M-119.09M-92.25M-728.65M-210.31M177.05M-213.28M1.95B3.06B4.03B-2.44B13.62B-1.96B-4.96B-1.35B1.44B-2.29B-1.51B-474.00M1.48B-868.00M-742.00M
Capital Expenditure300.00K1.20M2.60M6.70M2.70M3.70M51.50M15.85M44.44M61.38M36.92M28.03M63.81M44.80M35.09M22.00M569.25M16.82M385.95M181.13M184.96M470.60M303.30M291.00M336.00M235.00M278.00M309.00M283.00M268.00M272.00M337.00M397.00M
Free Cash Flow-2.40M1.40M28.50M-12.30M1.60M49.90M29.50M86.65M239.69M272.72M245.06M249.06M434.30M477.13M305.77M182.33M-208.35M246.37M290.52M475.44M857.00M1.82B1.90B1.80B1.95B1.27B1.22B802.00M1.14B-996.00M760.00M1.26B1.00B
Dividends Paid600.00K-----------79.78M80.06M321.52M180.29M147.15M356.29M52.50M08.48B8.20M17.86B9.00M18.00M----31.00M---
FCF to OCF114.29%53.85%91.64%219.64%37.21%93.10%36.42%84.54%84.36%81.63%86.91%89.88%87.19%91.42%89.71%89.23%-57.73%93.61%42.95%72.41%82.25%79.49%86.22%86.06%85.33%84.34%81.48%72.19%80.15%136.81%73.64%78.90%71.64%
Dividend Paid to FCF-25.00%-----------18.37%16.78%105.15%98.88%-70.62%144.62%18.07%0.00%989.35%0.45%941.18%0.50%0.92%-----3.11%---

Earnings

Report DateApr 17, 1996Jul 17, 1996Oct 29, 1996Feb 27, 1997Apr 28, 1997Jul 24, 1997Feb 25, 1998Apr 29, 1998Jul 28, 1998Nov 27, 1998Feb 26, 1999Apr 29, 1999Jul 28, 1999Oct 28, 1999Feb 24, 2000Apr 28, 2000Aug 2, 2000Oct 27, 2000Feb 28, 2001Apr 26, 2001Aug 1, 2001Oct 29, 2001Feb 21, 2002Apr 25, 2002Jul 25, 2002Oct 29, 2002Mar 4, 2003Apr 29, 2003Jul 29, 2003Oct 30, 2003Mar 3, 2004Apr 29, 2004Aug 4, 2004Nov 4, 2004Mar 10, 2005May 5, 2005Aug 4, 2005Nov 11, 2005Mar 23, 2006May 11, 2006Aug 10, 2006Nov 9, 2006Mar 15, 2007May 10, 2007Aug 8, 2007Nov 8, 2007Mar 13, 2008May 8, 2008Aug 13, 2008Nov 6, 2008Feb 26, 2009May 6, 2009Aug 6, 2009Nov 5, 2009Feb 25, 2010May 6, 2010Aug 5, 2010Nov 4, 2010Feb 24, 2011May 9, 2011Aug 4, 2011Nov 3, 2011Feb 27, 2012May 3, 2012Aug 2, 2012Nov 2, 2012Feb 28, 2013May 2, 2013Aug 7, 2013Oct 31, 2013Feb 27, 2014May 8, 2014Jul 31, 2014Oct 20, 2014Feb 22, 2015Apr 29, 2015Jul 23, 2015Oct 19, 2015Mar 15, 2016Jun 7, 2016Aug 9, 2016Nov 8, 2016Feb 28, 2017May 9, 2017Aug 8, 2017Nov 7, 2017Feb 28, 2018May 8, 2018Aug 7, 2018Nov 6, 2018Feb 20, 2019May 6, 2019Aug 6, 2019Nov 4, 2019Feb 19, 2020May 7, 2020Aug 6, 2020Nov 3, 2020Feb 24, 2021May 4, 2021Aug 3, 2021Nov 2, 2021Feb 23, 2022May 10, 2022Aug 9, 2022Nov 3, 2022Feb 23, 2023May 4, 2023Aug 3, 2023Nov 2, 2023Feb 22, 2024May 2, 2024Aug 1, 2024Oct 30, 2024Feb 20, 2025Apr 30, 2025Jul 30, 2025Oct 29, 2025Feb 18, 2026Apr 29, 2026Jul 29, 2026Oct 28, 2026Nov 4, 2026
EPS Estimate0.030.040.060.060.060.070.080.070.090.120.130.090.120.170.190.100.160.250.260.180.250.360.430.300.380.460.570.380.460.390.280.130.250.360.500.080.260.610.740.350.460.640.770.390.370.400.390.380.350.270.320.300.340.410.370.280.320.420.450.500.650.570.850.961.001.131.201.251.281.422.061.731.901.992.552.342.472.702.621.371.471.761.200.820.960.890.970.600.800.860.840.861.061.091.130.880.651.041.120.950.951.061.121.030.910.780.950.680.730.921.020.720.881.021.130.850.941.061.210.690.961.081.08
EPS Actual0.050.060.060.070.060.070.130.070.090.120.140.090.120.180.200.100.170.270.280.200.300.370.460.320.390.470.600.390.520.220.280.180.280.310.580.070.340.740.770.430.500.830.930.590.400.420.450.350.370.360.340.290.340.320.560.310.34-0.280.510.620.730.660.941.141.011.151.221.301.341.432.151.761.912.112.582.362.562.742.501.271.401.551.260.781.051.040.980.880.931.151.031.031.071.211.150.890.461.311.331.020.971.151.280.720.550.761.030.530.811.031.150.590.981.131.160.610.911.161.080.781.261.77-
Surprise66.67%50.00%0.00%16.67%0.00%0.00%62.50%0.00%0.00%0.00%7.69%0.00%0.00%5.88%5.26%0.00%6.25%8.00%7.69%11.11%20.00%2.78%6.98%6.67%2.63%2.17%5.26%2.63%13.04%-43.59%0.00%38.46%12.00%-13.89%16.00%-12.50%30.77%21.31%4.05%22.86%8.70%29.69%20.78%51.28%8.11%5.00%15.38%-7.89%5.71%33.33%6.25%-3.33%0.00%-21.95%51.35%10.71%6.25%-166.67%13.33%24.00%12.31%15.79%10.59%18.75%1.00%1.77%1.67%4.00%4.69%0.70%4.37%1.73%0.53%6.03%1.18%0.85%3.64%1.48%-4.58%-7.30%-4.76%-11.93%5.00%-4.88%9.38%16.85%1.03%46.67%16.25%33.72%22.62%19.77%0.94%11.01%1.77%1.14%-29.23%25.96%18.75%7.37%2.11%8.49%14.29%-30.10%-39.56%-2.56%8.42%-22.06%10.96%11.96%12.75%-18.06%11.36%10.78%2.96%-28.24%-3.19%9.43%-10.74%13.04%31.25%63.89%-
Timing----Pre-marketPre-marketPre-marketPre-marketPre-market------------Pre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-

Key Statistics & Ratios

Market Cap3.33B
Enterprise Value21.53B
Trailing P/E0.00
Forward P/E1.55
PEG Ratio0.01
Price / Sales0.31
Price / Book18.78
EPS-2.95
Book Value-1.50
Revenue (TTM)10.85B
Gross Profit (TTM)7.79B
EBITDA3.91B
Profit Margin-10.12%
Operating Margin27.17%
Return on Equity43.64%
Return on Assets6.57%
Shares Outstanding373.99M
Shares Float260.57M
Beta0.37
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 7 analystsTarget 7.50
  • Hold
    7

Ownership Breakdown

Institutions
65.22%
Insiders
11.12%
Retail / Other
23.66%

Top Institutional Holders

  • Paulson & Company Inc
    73.26M19.59%
  • Goldentree Asset Management LP
    34.67M9.27%
  • Royal Bank of Canada
    10.83M2.90%
  • HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
    8.00M2.14%
  • Vanguard Capital Management, LLC
    7.47M2.00%
  • The Goldman Sachs Group Inc
    6.23M1.66%
  • MFN Partners Management, LP
    6.00M1.60%
  • SG Americas Securities, LLC
    5.54M1.48%
  • Acadian Asset Management LLC
    5.48M1.47%
  • Kohlberg Kravis Roberts & Co LP
    5.24M1.40%
  • ING Groep NV
    5.00M1.34%
  • Hudson Bay Capital Management LP
    5.00M1.34%
  • Geode Capital Management, LLC
    4.80M1.28%
  • Gendell Jeffrey L
    4.04M1.08%
  • NORGES BANK
    3.43M0.92%
  • Macquarie Group Ltd
    3.25M0.87%
  • Dimensional Fund Advisors, Inc.
    3.24M0.87%
  • D. E. Shaw & Co LP
    2.69M0.72%

Top Fund Holders

  • Vanguard Total Intl Stock Index Inv
    3.76M1.01%
  • Fidelity Canadian Value ETF
    3.08M0.82%

Dividends

20104×
1.00Nov 10, 20100.10Aug 30, 20100.10May 28, 20100.09Mar 4, 2010
20094×
0.09Nov 30, 20090.09Aug 28, 20090.09May 13, 20090.38Mar 6, 2009
20084×
0.38Dec 19, 20080.38Aug 21, 20080.38May 20, 20080.38Mar 25, 2008
20075×
0.38Nov 16, 20070.38Aug 16, 20070.36May 17, 20070.38Mar 22, 20070.50Jan 8, 2007
20064×
0.13Nov 20, 20060.13Aug 16, 20060.13May 19, 20060.13Apr 5, 2006
20051×
0.50Nov 28, 2005

Stock Splits

  • Oct 16, 20002:1
  • Jan 20, 20002:1
  • Jan 17, 19963:1